By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A lung cancer drug reduced the risk of death by 34% in a late-stage trial, in the latest sign of China’s pharmaceutical ...

An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, ...

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival ...

Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...

Scientists at Nagoya University in Japan studied what happens when macrophages—a type of immune cell—encounter dying cancer cells in tumors and discovered a mechanism that accelerates tumor growth.

The American Cancer Society’s annual cancer trends report revealed a mix of news and statistics for 2025. Cancer death rates have dropped 34% between 1991 and 2022, which the ACS attributes to early ...

Colorectal cancer has become the leading cause of cancer death among people under 50 in the United States – and the reasons why are still murky, a new report says. In the early 1990s, colorectal ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...

At least 200 concerned residents packed the Keyport High School gym Sunday night, fearing for their community. They came armed with questions — and plenty of anger — about an alarming number of cancer ...